1 / 7

Li-Fraumeni Syndrome

Li-Fraumeni Syndrome. By: Amber Spiering, Lisa Smith, Dan Poor, Jason Powell, Amit Khosla, & Liz Viola. What is Li-Fraumeni Syndrome?. Studies by Li and Fraumeni led to first evidence of inherited predisposition to cancer. Modes of Inheritance:. Phenotype looks autosomal dominant

jontae
Télécharger la présentation

Li-Fraumeni Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Li-Fraumeni Syndrome By: Amber Spiering, Lisa Smith, Dan Poor, Jason Powell, Amit Khosla, & Liz Viola

  2. What is Li-Fraumeni Syndrome? • Studies by Li and Fraumeni led to first evidence of inherited predisposition to cancer

  3. Modes of Inheritance: • Phenotype looks autosomal dominant • Molecular level autosomal recessive

  4. Main Symptoms: • the presence of sarcoma in a proband at less than 45 years of age, combined with • sarcoma, breast cancer, primary brain tumor, leukemia, or adrenocortical carcinoma in a first-degree relative younger than 45 years of age and • cancer diagnosed in another close relative less than 45 years old or sarcoma at any age.

  5. Frequency of Syndrome: • Case Study of 5 Families: • By 40 years of age 50% had Cancer • By 60 years of age 90% had Cancer • Lifetime Cancer Risk 85% • 5-10 cases of soft-tissue sarcoma/1million children under 15 years old (5-10% of which have family histories of malignancies consistent with LFS)

  6. Biochemistry Behind Trait: • TP53(p53), a tumor suppressor gene, which is located on chromosome 17p13 • Most mutations occur in exons 4,5,6,7,8 • Types of mutations include: • missense mutations (86%). • nonsense mutations (5%) • deletions or insertions (8%) • splice-site acceptor mutations

More Related